These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 21153329)

  • 21. C1q/TNF-related protein-3 represents a novel and endogenous lipopolysaccharide antagonist of the adipose tissue.
    Kopp A; Bala M; Buechler C; Falk W; Gross P; Neumeier M; Schölmerich J; Schäffler A
    Endocrinology; 2010 Nov; 151(11):5267-78. PubMed ID: 20739398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atorvastatin decreases Toll-like receptor 4 expression and downstream signaling in human monocytic leukemia cells.
    Yang SS; Li R; Qu X; Fang W; Quan Z
    Cell Immunol; 2012 Sep; 279(1):96-102. PubMed ID: 23103560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysfunctional mitochondria contain endogenous high-affinity human Toll-like receptor 4 (TLR4) ligands and induce TLR4-mediated inflammatory reactions.
    Nicholas SA; Coughlan K; Yasinska I; Lall GS; Gibbs BF; Calzolai L; Sumbayev VV
    Int J Biochem Cell Biol; 2011 Apr; 43(4):674-81. PubMed ID: 21262374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced expression of TLR4 is associated with the metastatic status of human colorectal cancer.
    Simiantonaki N; Kurzik-Dumke U; Karyofylli G; Jayasinghe C; Michel-Schmidt R; Kirkpatrick CJ
    Int J Mol Med; 2007 Jul; 20(1):21-9. PubMed ID: 17549384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attenuation of proliferation in oligodendrocyte precursor cells by activated microglia.
    Taylor DL; Pirianov G; Holland S; McGinnity CJ; Norman AL; Reali C; Diemel LT; Gveric D; Yeung D; Mehmet H
    J Neurosci Res; 2010 Jun; 88(8):1632-44. PubMed ID: 20091773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IFNβ produced by TLR4-activated tumor cells is involved in improving the antitumoral immune response.
    Núñez NG; Andreani V; Crespo MI; Nocera DA; Breser ML; Morón G; Dejager L; Libert C; Rivero V; Maccioni M
    Cancer Res; 2012 Feb; 72(3):592-603. PubMed ID: 22139376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigallocatechin-3-gallate-mediated Tollip induction through the 67-kDa laminin receptor negatively regulating TLR4 signaling in endothelial cells.
    Byun EB; Mi-SoYang ; Kim JH; Song DS; Lee BS; Park JN; Park SH; Park C; Jung PM; Sung NY; Byun EH
    Immunobiology; 2014 Nov; 219(11):866-72. PubMed ID: 25109435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of homodimerization of Toll-like receptor 4 by curcumin.
    Youn HS; Saitoh SI; Miyake K; Hwang DH
    Biochem Pharmacol; 2006 Jun; 72(1):62-9. PubMed ID: 16678799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TLR ligand decreases mesenteric ischemia and reperfusion injury-induced gut damage through TNF-alpha signaling.
    Chen LW; Chang WJ; Chen PH; Liu WC; Hsu CM
    Shock; 2008 Nov; 30(5):563-70. PubMed ID: 18317407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFκB signaling, MAPK, and Jak1/Stat1 pathways.
    Gorina R; Font-Nieves M; Márquez-Kisinousky L; Santalucia T; Planas AM
    Glia; 2011 Feb; 59(2):242-55. PubMed ID: 21125645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leishmania donovani targets tumor necrosis factor receptor-associated factor (TRAF) 3 for impairing TLR4-mediated host response.
    Gupta P; Giri J; Srivastav S; Chande AG; Mukhopadhyaya R; Das PK; Ukil A
    FASEB J; 2014 Apr; 28(4):1756-68. PubMed ID: 24391131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platycodon grandiflorum polysaccharide induces dendritic cell maturation via TLR4 signaling.
    Park MJ; Ryu HS; Kim JS; Lee HK; Kang JS; Yun J; Kim SY; Lee MK; Hong JT; Kim Y; Han SB
    Food Chem Toxicol; 2014 Oct; 72():212-20. PubMed ID: 25019244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells.
    Ando T; Ichikawa J; Wako M; Hatsushika K; Watanabe Y; Sakuma M; Tasaka K; Ogawa H; Hamada Y; Yagita H; Nakao A
    Arthritis Res Ther; 2006; 8(5):R146. PubMed ID: 16945157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heat shock protein gp96 and NAD(P)H oxidase 4 play key roles in Toll-like receptor 4-activated apoptosis during renal ischemia/reperfusion injury.
    Ben Mkaddem S; Pedruzzi E; Werts C; Coant N; Bens M; Cluzeaud F; Goujon JM; Ogier-Denis E; Vandewalle A
    Cell Death Differ; 2010 Sep; 17(9):1474-85. PubMed ID: 20224597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statins inhibit toll-like receptor 4-mediated lipopolysaccharide signaling and cytokine expression.
    Hodgkinson CP; Ye S
    Pharmacogenet Genomics; 2008 Sep; 18(9):803-13. PubMed ID: 18698233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple mechanisms involved in diabetes protection by lipopolysaccharide in non-obese diabetic mice.
    Wang J; Cao H; Wang H; Yin G; Du J; Xia F; Lu J; Xiang M
    Toxicol Appl Pharmacol; 2015 Jun; 285(3):149-58. PubMed ID: 25896969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Priming of Toll-like receptor 4 pathway in mesenchymal stem cells increases expression of B cell activating factor.
    Yan H; Wu M; Yuan Y; Wang ZZ; Jiang H; Chen T
    Biochem Biophys Res Commun; 2014 May; 448(2):212-7. PubMed ID: 24780395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic cross-talk analysis among TNF-R, TLR-4 and IL-1R signalings in TNFalpha-induced inflammatory responses.
    Yang SK; Wang YC; Chao CC; Chuang YJ; Lan CY; Chen BS
    BMC Med Genomics; 2010 May; 3():19. PubMed ID: 20497537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of TLR4 in Chemotherapy-Driven Metastasis.
    Ran S
    Cancer Res; 2015 Jun; 75(12):2405-10. PubMed ID: 25998620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of differentiation as a means of modifying metastatic behaviour.
    Hart IR; Goode NT; Ormerod EJ
    Adv Exp Med Biol; 1988; 233():361-5. PubMed ID: 3066157
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.